Low dose rabbit antithymocyte globulin is non-inferior to higher dose in low-risk pediatric kidney transplant recipients

被引:0
作者
Vaka K. Sigurjonsdottir
Lynn Maestretti
Anne McGrath
Waldo Concepcion
Amy Gallo
Urdur Jonsdottir
Paul C. Grimm
Abanti Chaudhuri
机构
[1] Stanford University,Division of Nephrology, Department of Pediatrics
[2] University of Iceland,Faculty of Medicine, School of Health Sciences
[3] Landspitali–The National University Hospital of Iceland,Transplantation Services
[4] Mohamed Bin Rashid University,Division of Abdominal Transplantation, Department of Surgery
[5] Stanford University,undefined
来源
Pediatric Nephrology | 2022年 / 37卷
关键词
Induction therapy; Thymoglobulin; Transplantation; Acute allograft rejection; Immunosuppression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2091 / 2098
页数:7
相关论文
共 113 条
[1]  
Pascual J(2004)Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials Transplantation 78 1548-1556
[2]  
Quereda C(2016)Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial Lancet 388 3006-3016
[3]  
Zamora J(2017)Corticosteroid use and growth after pediatric solid organ transplantation: a systematic review and meta-analysis Transplantation 101 694-703
[4]  
Hernández D(2012)Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up Am J Transplant 12 2719-2729
[5]  
Thomusch O(2006)Rabbit antithymocyte globulin versus basiliximab in renal transplantation N Engl J Med 355 1967-1977
[6]  
Wiesener M(2017)Comparing outcomes between antibody induction therapies in kidney transplantation J Am Soc Nephrol 28 2188-2200
[7]  
Opgenoorth M(2020)Reassessing rabbit antithymocyte globulin induction in kidney transplantation (RETHINK): an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry Transplant Direct 6 e598-818
[8]  
Pascher A(2002)Short-term outcomes of thymoglobulin induction in pediatric renal transplant recipients Pediatr Nephrol 17 815-1392
[9]  
Tsampalieros A(2009)Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients J Am Soc Nephrol 20 1385-1520
[10]  
Knoll GA(2010)Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation Transplantation 90 1516-1002